+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
From
Follicular Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Follicular Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
Marginal Zone Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Marginal Zone Lymphoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 150 Pages
  • Global
From
Myelodysplastic Syndrome Market Report 2025 - Product Thumbnail Image

Myelodysplastic Syndrome Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
Interstitial Cystitis Market Report 2025 - Product Thumbnail Image

Interstitial Cystitis Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
Chronic Lymphocytic Leukemia- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Lymphocytic Leukemia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 210 Pages
  • Global
From
From
From
IgE Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

IgE Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator